GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CPIX · Jun 30, 2026

CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001087294-26-000062General Corporate
Revenue growth5thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

-18.79% · CORE · VALID

Inventory pressure0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

0.34% · OPTIONAL · VALID

Operating margin0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

-35.91% · CORE · VALID

R&D intensity0thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

8.77% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition

What moved in the state?

Growth Increased
Previous
-22.04%
Current
-18.79%
Delta
3.25%
Inventory Pressure Decreased
Previous
59.73%
Current
0.34%
Delta
-59.39%
Profitability Decreased
Previous
-34.27%
Current
-35.91%
Delta
-1.64%
R And D Intensity Decreased
Previous
15.97%
Current
8.77%
Delta
-7.20%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Dec 31, 2023
Similarity
77%
Compared
4 dimensions
Coverage
100%
Growth 30.0 · Profitability 0.0 · R And D Intensity 35.0 · Inventory Pressure 0.0
Mar 31, 2016
Similarity
75%
Compared
4 dimensions
Coverage
100%
Growth 41.7 · Profitability 15.8 · R And D Intensity 10.5 · Inventory Pressure 21.1
Sep 30, 2015
Similarity
72%
Compared
4 dimensions
Coverage
100%
Growth 33.5 · Profitability 23.5 · R And D Intensity 23.5 · Inventory Pressure 29.4
Sep 30, 2024
Similarity
72%
Compared
4 dimensions
Coverage
100%
Growth 20.0 · Profitability 25.0 · R And D Intensity 35.0 · Inventory Pressure 30.0
Sep 30, 2025
Similarity
62%
Compared
4 dimensions
Coverage
100%
Growth 30.0 · Profitability 5.0 · R And D Intensity 60.0 · Inventory Pressure 35.0
Research Graph

Related governed research

Analogous To · CPIX state analogue 4 →Analogous To · CPIX state analogue 2 →Analogous To · CPIX state analogue 5 →Analogous To · CPIX state analogue 3 →Compared To · Pharmaceutical Preparations peers →Analogous To · CPIX state analogue 1 →Has State · CUMBERLAND PHARMACEUTICALS INC →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX GROWTH_INCREASED →Transitioned To · CPIX INVENTORY_PRESSURE_DECREASED →Transitioned To · CPIX PROFITABILITY_DECREASED →Transitioned To · CPIX R_AND_D_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.